Description
The FDA is issuing a Broad Agency Announcement (BAA) to fund extramural research and development projects that advance regulatory science across the full spectrum of FDA‑regulated products. The solicitation is open to all responsible sources, with a strong encouragement for small businesses, and will result in cost‑type procurement contracts. Proposals must be submitted in two stages (concept paper and full technical/cost proposal) by the January 22 2027 deadline. The BAA outlines 22 priority research areas ranging from modernizing clinical trials to cybersecurity for medical devices, and requires detailed technical deliverables, monthly progress reports, and a final 508‑compliant report.